# Development of a risk prediction model for left ventricular thrombosis in STEMI patients

**Authors:** Jingjing Wang, Ping Ma, QingBin Xu, Lan Hai, Shichang Zhang

PMC · DOI: 10.3389/fcvm.2026.1704792 · Frontiers in Cardiovascular Medicine · 2026-02-04

## TL;DR

This study developed a risk prediction model to identify patients with heart attacks who are at higher risk of developing blood clots in the left ventricle.

## Contribution

A novel multivariate logistic regression model with high accuracy for predicting left ventricular thrombosis in STEMI patients.

## Key findings

- Seven clinical variables were identified as independent risk factors for LVT in STEMI patients.
- The model showed excellent discrimination with a C-index of 0.966 and high internal validation accuracy.
- Variables like D-dimer, CRP, and pericardial effusion were strongly associated with LVT risk.

## Abstract

To develop a risk prediction model for left ventricular thrombus (LVT) formation in patients with acute ST-segment elevation myocardial infarction (STEMI).

We performed a retrospective analysis of patients with STEMI in our hospital between October 2017 to October 2020. According to transthoracic echocardiography, these patients were included in the LVT group (n = 50) or no-LVT group (n = 130). Clinical data were collected from both groups. The comparison between groups, single-factor logistic regression analysis, Lasso regression analysis and multi-factor logistic regression analysis were performed successively to screen the risk factors and to establish risk prediction models. After evaluation and internal verification, we obtained an optimal risk prediction model. A nomogram was constructed to visualize the optimal model.

The risk prediction model contained seven variables including MCV (OR = 1.251, 95% CI = 1.021–1.531, P = 0.030), D-Dimer (OR = 9.798, 95% CI = 2.630–36.503, P = 0.001), CRP (OR = 1.033, 95% CI = 1.011–1.055, P = 0.003), LVEF (OR = 0.903, 95% CI = 0.819–0.995, P = 0.040), A wave velocity (OR = 0.044, 95% CI = 0.002–0.906, P = 0.043), pericardial effusion (OR = 16.926, 95% CI = 2.767–103.522, P = 0.002) and anterior wall infarction (OR = 12.275, 95% CI = 2.136–70.548, P = 0.005). The C-index value was 0.966 and the area under the ROC curve was 96.6% (95% CI = 0.9399–0.9914). Simple cross-validation, k-fold, leave-one-out, and bootstrap analyses were used to internally verify the model. The accuracy of the model were 0.926, 0.9, 0.9, and 0.899, and Kappa values were 0.807, 0.744, 0.744, and 0.739. The area under the ROC curve was 94.7%, as verified by bootstrapping.

MCV, D-dimer level, CRP level, LVEF, A-wave velocity, pericardial effusion, and anterior wall infarction were independently related to the occurrence of LVT in STEMI at the acute stage. The multivariate logistic regression risk prediction model developed in this study demonstrates good discrimination and calibration, enabling preliminary risk stratification for LVT in patients with acute STEMI.

## Linked entities

- **Diseases:** ST-segment elevation myocardial infarction (MONDO:0041656)

## Full-text entities

- **Genes:** CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, GPT (glutamic--pyruvic transaminase) [NCBI Gene 2875] {aka AAT1, ALT, ALT1, GPT1, SGPT}, FGB (fibrinogen beta chain) [NCBI Gene 2244] {aka HEL-S-78p}, NPPB (natriuretic peptide B) [NCBI Gene 4879] {aka BNP, Iso-ANP}
- **Diseases:** heart failure (MESH:D006333), infarct (MESH:D007238), microvascular embolism (MESH:D004617), cardiac dysfunction (MESH:D006331), MCV (MESH:D009800), coronary artery disease (MESH:D003324), hyperhomocysteinemia (MESH:D020138), anterior wall infarction (MESH:D056988), ischemic stroke (MESH:D002544), myocardial ischemia (MESH:D017202), end-stage renal disease (MESH:D007676), cardiovascular death (MESH:D002318), dilated cardiomyopathy (MESH:D002311), acute myocardial infarction (MESH:D009203), arterial or venous thrombosis (MESH:D020246), LVT (MESH:D013927), anemia (MESH:D000740), atherosclerosis (MESH:D050197), Killip II (MESH:C537730), VTE (MESH:D054556), malnutrition (MESH:D044342), abnormal lipid metabolism (MESH:D052439), thrombotic hematological diseases (MESH:D006402), hypertension (MESH:D006973), Pericardial effusion (MESH:D010490), MR (MESH:D008944), left anterior descending artery disease (MESH:D020759), ST-segment elevation myocardial infarction (MESH:D000072657), left ventricular aneurysm (MESH:D018487), stroke (MESH:D020521), heart rupture (MESH:D006341), chest pain (MESH:D002637), myocardial injury (MESH:D009202), endothelial dysfunction (MESH:D014652), valve diseases (MESH:D006349), papillary muscle rupture (MESH:D012421), left anterior descending branch lesion (MESH:D002037), diabetes (MESH:D003920), ventricular aneurysm (MESH:D000783), critically ill (MESH:D016638), platelet aggregation (MESH:D001791), acute inflammation (MESH:D007249), disease (MESH:D004194), acute coronary syndrome (MESH:D054058), dyslipidemia (MESH:D050171)
- **Chemicals:** cTn (MESH:C403585), homocysteine (MESH:D006710), D (MESH:D003903)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12913553/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12913553/full.md

## References

30 references — full list in the complete paper: https://tomesphere.com/paper/PMC12913553/full.md

---
Source: https://tomesphere.com/paper/PMC12913553